218 related articles for article (PubMed ID: 10936478)
1. Third-generation thrombolytic drugs.
Verstraete M
Am J Med; 2000 Jul; 109(1):52-8. PubMed ID: 10936478
[TBL] [Abstract][Full Text] [Related]
2. Newer thrombolytic agents.
Verstraete M
Ann Acad Med Singap; 1999 May; 28(3):424-33. PubMed ID: 10575530
[TBL] [Abstract][Full Text] [Related]
3. New thrombolytic drugs.
Thomson A
Aust N Z J Med; 1999 Jun; 29(3):433-5. PubMed ID: 10868516
[TBL] [Abstract][Full Text] [Related]
4. The role of thrombolytic drugs in the management of myocardial infarction. Comparative clinical trials.
Weaver WD
Eur Heart J; 1996 Dec; 17 Suppl F():9-15. PubMed ID: 8960443
[TBL] [Abstract][Full Text] [Related]
5. Fibrin binding and the regulation of plasminogen activators during thrombolytic therapy.
Longstaff C; Williams S; Thelwell C
Cardiovasc Hematol Agents Med Chem; 2008 Jul; 6(3):212-23. PubMed ID: 18673235
[TBL] [Abstract][Full Text] [Related]
6. [Thrombolytic therapy of ischemic stroke].
Gusev EI; Martynov MY; Yasamanova AN; Nikonov AA; Markin SS; Semenov AM
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(12. Vyp. 2):4-14. PubMed ID: 30830111
[TBL] [Abstract][Full Text] [Related]
7. [Development of new thrombolytic substances].
Zeymer U; Neuhaus KL
Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction.
Tanswell P; Modi N; Combs D; Danays T
Clin Pharmacokinet; 2002; 41(15):1229-45. PubMed ID: 12452736
[TBL] [Abstract][Full Text] [Related]
9. New thrombolytic agents and strategies.
Collen D; Lijnen HR
Baillieres Clin Haematol; 1995 Jun; 8(2):425-35. PubMed ID: 7549072
[TBL] [Abstract][Full Text] [Related]
10. Newer thrombolytic drugs for acute myocardial infarction.
Reddy DS
Indian J Exp Biol; 1998 Jan; 36(1):1-15. PubMed ID: 9536645
[TBL] [Abstract][Full Text] [Related]
11. Reteplase: a new thrombolytic for the treatment of acute myocardial infarction.
Wooster MB; Luzier AB
Ann Pharmacother; 1999 Mar; 33(3):318-24. PubMed ID: 10200858
[TBL] [Abstract][Full Text] [Related]
12. Patency trials with reteplase (r-PA): what do they tell us?
Bode C; Nordt TK; Peter K; Smalling RW; Runge MS; Kübler W
Am J Cardiol; 1996 Dec; 78(12A):16-9. PubMed ID: 8990406
[TBL] [Abstract][Full Text] [Related]
13. Advances in thrombolytic therapy.
Verstraete M
Cardiovasc Drugs Ther; 1992 Apr; 6(2):111-24. PubMed ID: 1390321
[TBL] [Abstract][Full Text] [Related]
14. A review of available fibrin-specific thrombolytic agents used in acute myocardial infarction.
Tsikouris JP; Tsikouris AP
Pharmacotherapy; 2001 Feb; 21(2):207-17. PubMed ID: 11213858
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of tenecteplase in acute myocardial infarction.
Guerra DR; Karha J; Gibson CM
Expert Opin Pharmacother; 2003 May; 4(5):791-8. PubMed ID: 12740001
[TBL] [Abstract][Full Text] [Related]
16. Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics.
Bell WR
Rev Cardiovasc Med; 2002; 3 Suppl 2():S34-44. PubMed ID: 12556741
[TBL] [Abstract][Full Text] [Related]
17. Fibrin specificity and procoagulant effect related to the kallikrein-contact phase system and to plasmin generation with double-bolus reteplase and front-loaded alteplase thrombolysis in acute myocardial infarction.
Hoffmeister HM; Kastner C; Szabo S; Beyer ME; Helber U; Kazmaier S; Baumbach A; Wendel HP; Heller W
Am J Cardiol; 2000 Aug; 86(3):263-8. PubMed ID: 10922430
[TBL] [Abstract][Full Text] [Related]
18. Bacterial staphylokinase as a promising third-generation drug in the treatment for vascular occlusion.
Nedaeinia R; Faraji H; Javanmard SH; Ferns GA; Ghayour-Mobarhan M; Goli M; Mashkani B; Nedaeinia M; Haghighi MHH; Ranjbar M
Mol Biol Rep; 2020 Jan; 47(1):819-841. PubMed ID: 31677034
[TBL] [Abstract][Full Text] [Related]
19. Thrombolytic agents in development.
Verstraete M; Lijnen HR; Collen D
Drugs; 1995 Jul; 50(1):29-42. PubMed ID: 7588087
[TBL] [Abstract][Full Text] [Related]
20. [t-PA in thrombolytic therapy of acute myocardial infarct].
Rutsch W; Schmutzler H
Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
